Saturday 17 October 2026 Export BNGO’s income statement to Excel — free account

Bionano Genomics, Inc.

BNGO Healthcare Medical Instruments & Supplies

Bionano Genomics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $28.5 million, down 7.37% from fiscal 2024. In the quarter to June 2026, revenue grew 21.4%, EPS grew 67.8%, free cash flow fell 33.9% and total debt fell 1.91%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

1.25 0.12 −8.76%

Follow BNGO

Alert me

Market cap: $16.1M
P/E: 0.0×
Fwd P/E: −0.6×
Dividend yield: —
F-score: 5/9
Altman Z: −14.26
Beneish M: −3.39
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	0.00	0.00	0.00	0.00
P/S ratio Full definition →		0.32	0.29	0.45	0.43
P/FCF ratio Full definition →		0.00	0.00	0.00	0.00
P/Operating CF Full definition →		(1.54)	(2.00)	(2.25)	(2.79)
P/B ratio Full definition →		0.18	0.19	0.34	0.41
Price to Tangible BV Full definition →		0.21	0.21	0.37	0.44
EV/Sales Full definition →		(0.17)	(0.12)	0.20	0.67
EV/EBITDA Full definition →		0.18	0.14	0.00	0.00
EV/Operating CF Full definition →		0.27	0.21	(0.30)	(0.99)
EV/FCF Full definition →		0.27	0.21	(0.30)	(0.99)
Quick Ratio Full definition →		1.58	1.51	1.36	1.47
Current Ratio Full definition →		2.12	1.98	1.84	2.48
Net Debt/EBITDA Full definition →		4.47	4.07	3.70	1.40
Debt/Assets Full definition →		4.42%	4.73%	5.34%	7.24%
Debt/Equity Full definition →		0.07	0.08	0.09	0.11
Asset Turnover Full definition →		0.35	0.38	0.40	0.49
Operating CF/Net income Full definition →		0.70	0.53	0.69	0.63
Capex/Depreciation Full definition →		0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →		38.60%	40.61%	46.94%	36.57%
Selling, General and Administrative Expense of Revenue Full definition →		123.04%	109.51%	119.78%	104.56%
Intangible Assets out of Total Assets Full definition →		0.07	0.06	0.05	0.04
Share Based Compensation of Revenue Full definition →		12.77%	11.65%	10.02%	11.87%
Graham Net Nets Full definition →		2.14	1.95	0.91	0.68
Graham Number Full definition →		0.00	0.00	0.00	0.00
Earnings Yield Full definition →		(689.32%)	(311.11%)	(373.50%)	(267.26%)
Free Cash Flow Yield Full definition →		(205.71%)	(197.43%)	(151.03%)	(157.76%)
Revenue per Share Full definition →		1.38	1.46	0.61	0.71
Operating CF per Share Full definition →		(1.11)	(0.77)	(0.52)	(0.40)
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		(1.11)	(0.77)	(0.52)	(0.40)
Cash per Share Full definition →		5.97	5.42	2.25	0.90
Shareholders Equity per Share Full definition →		9.33	8.16	3.41	2.74
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		9.33	8.16	3.41	2.74
Free Cash Flow Full definition →		(5.92)	(4.17)	(5.72)	(4.67)
Working Capital Full definition →		25.82	22.44	17.75	14.84
Net Current Asset Value Full definition →		19.54	16.23	11.63	8.89
EV/EBIT Full definition →		0.14	0.10	0.00	0.00
Capex to Sales Full definition →		0.00	0.00	0.00	0.00
Price to Operating Income Full definition →		0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →		4.92	4.98	3.74	3.93
Average Payables Full definition →		7.35	6.28	5.81	5.40
Average Inventory Full definition →		10.69	8.28	7.43	6.92
Average Assets Full definition →		83.21	75.13	71.61	61.80
Average Common Equity Full definition →		49.33	39.90	42.83	38.49

Fold the line items

Columns are period end dates

Stockrow Weekly